Professional
Added to YB: 2025-10-29
Pitch date: 2025-09-30
FTRE [neutral]
Fortrea Holdings Inc.
+85.6%
current return
Author Info
No bio for this author
Company Info
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.
Market Cap
$961.9M
Pitch Price
$8.47
Price Target
N/A
Dividend
N/A
EV/EBITDA
85.02
P/E
-0.92
EV/Sales
0.73
Sector
Life Sciences Tools and Services
Category
turnaround
Curreen Capital Partners Portfolio Holding: Fortrea Holdings Inc.
FTRE (holding update): CRO spun from Labcorp June 2023, helps biotech/pharma run clinical trials for marketing authorization. Designs trials, recruits investigators/participants, prepares regulatory data. Currently executing turnaround strategy. Trades at attractive upside-to-downside ratio.
Read full article (1 min)